← Back to Search

Pectoral Nerve Blocks with Bupivacaine for Device Placement

Phase 2 & 3

Recruiting

Research Sponsored by Beth Israel Deaconess Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 1 hour, 12 hour and 24hours

Awards & highlights

Study Summary

This trial will compare the effectiveness of a local anesthetic to a placebo for pain relief during a medical procedure.

Eligible Conditions

Pain
Opioid Abuse
Acute Pain
Postoperative Pain
Opioid Use Disorder
Patient Satisfaction
Chest Pain

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 1 hour, 12 hour and 24hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 1 hour, 12 hour and 24hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 1 hour, 12 hour and 24hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Opioid consumption

Secondary outcome measures

Pain scores on a scale 1 - 10, 1 being the least pain and 10 being the worst pain

Patient satisfaction scores

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Bupivacaine GroupExperimental Treatment1 Intervention

Receive up to 25 ml of 0.25% bupivacaine hydrochloride for the Pecs block

Group II: Control groupPlacebo Group1 Intervention

Receive up to 25 ml of normal 0.9% sodium chloride for the Pecs block

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Bupivacaine

FDA approved

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor

836 Previous Clinical Trials

13,010,274 Total Patients Enrolled

8 Trials studying Pain

5,579 Patients Enrolled for Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any patients needed for this experiment?

"The study in question is not presently looking for participants, as the most recent update on clinicaltrials.gov indicates. This particular trial was posted on April 1st, 2022 and updated March 8th, 2023. There are however, 1062 other trials that are active right now."

Answered by AI

Recent research and studies

SpringerPlusJournal

Pectoral Nerves (PECS) and Intercostal Nerve Block for Cardiac Resynchronization Therapy Device Implantation

Fujiwara, Atsushi, Nobuyasu Komasawa, and Toshiaki Minami. 2014. “Pectoral Nerves (PECS) and Intercostal Nerve Block for Cardiac Resynchronization Therapy Device Implantation”. Springerplus. Springer Science and Business Media LLC. doi:10.1186/2193-1801-3-409.

Saudi Journal of AnaesthesiaJournal

Pectoralis Blocks for Insertion of an Implantable Cardioverter Defibrillator in Two Patients with Duchenne Muscular Dystrophy

Tobias, JosephD, AlexanderB Froyshteter, Tarun Bhalla, GregoryS Cambier, and ChristopherT Mckee. 2018. “Pectoralis Blocks for Insertion of an Implantable Cardioverter Defibrillator in Two Patients with Duchenne Muscular Dystrophy”. Saudi Journal of Anaesthesia. Medknow. doi:10.4103/sja.sja_624_17.

Regional Anesthesia and Pain MedicineJournal

Pectoral Nerves I and II Blocks in Multimodal Analgesia for Breast Cancer Surgery

Bashandy, Ghada Mohammad Nabih, and Dina Nabil Abbas. 2015. “Pectoral Nerves I and II Blocks in Multimodal Analgesia for Breast Cancer Surgery”. Regional Anesthesia and Pain Medicine. BMJ. doi:10.1097/aap.0000000000000163.

clinicaltrials.govStudy